[1]
Lamm, W. et al. 2012. Safety and efficacy of temsirolimus in heavily pretreated patients with metastatic renal cell carcinoma. Acta Oncologica. 51, 1 (Jan. 2012), 101–106. DOI:https://doi.org/10.3109/0284186X.2011.589404.